State Street® SPDR® S&P® Biotech ETF XBI

Medalist Rating as of | See State Street Investment Hub

Morningstar’s Analysis XBI

Will XBI outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

State Street® SPDR® S&P® Biotech ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings XBI

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 13.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Apogee Therapeutics Inc

1.61 160M
Healthcare

Oruka Therapeutics Inc

1.42 141M
Healthcare

Kymera Therapeutics Inc Ordinary Shares

1.41 140M
Healthcare

Erasca Inc

1.39 139M
Healthcare

Dianthus Therapeutics Inc

1.31 130M
Healthcare

Viking Therapeutics Inc

1.30 129M
Healthcare

Spyre Therapeutics Inc

1.28 128M
Healthcare

Moderna Inc

1.28 128M
Healthcare

Twist Bioscience Corp

1.28 127M
Healthcare

CG Oncology Inc

1.27 126M
Healthcare

Sponsor Center